Category C—Appears to result in least placental exposure.
Considered to be 1st-line drug for BF women, with a low RID, ranging from 0.5-3%; very few AEs described in the literature
Avoid use in patients ≥65 with a history of falls or fractures
No dosage adjustment necessary.
↓ dose 50% even in mild impairment. DO NOT USE if moderate-severe impairment.